Understanding Depressive and Related Disorders: A Clinical Review
This article provides a comprehensive clinical review of depressive and related disorders, covering DSM-5-TR diagnostic criteria, epidemiological considerations, and treatment modalities for conditions such as Major Depressive Disorder, Disruptive Mood Dysregulation Disorder, Persistent Depressive Disorder, and Premens
Depressive disorders represent a diverse spectrum of clinical presentations, ranging from acute, severe episodes to chronic, low-grade mood disturbances. Understanding the nuances between these diagnoses is critical for accurate clinical assessment, particularly when distinguishing between normal physiological responses—such as grief—and pathological states like Major Depressive Disorder (MDD). This article reviews the DSM-5-TR diagnostic criteria, epidemiological considerations, and treatment modalities for the various depressive and related disorders.
Major Depressive Disorder (MDD)
Major Depressive Disorder is characterized by discrete episodes of depressed mood or anhedonia (loss of interest or pleasure) that represent a change from previous functioning. While the specific duration and symptom counts are defined by the DSM, clinicians must look for a multidimensional array of symptoms.
Clinical Presentation and Findings
Clinicians evaluate patients through both subjective history and objective examination.
Subjective Findings (Patient History):
Mood and Interest: Sad mood, decreased libido, and anhedonia.
Vegetative Symptoms: Appetite changes (often loss of appetite leading to weight loss) and sleep disturbances (insomnia can be initial, middle, or terminal; hypersomnia is also possible).
Cognitive/Emotional: Fatigue, feelings of guilt, worthlessness, hopelessness, and poor concentration.
Suicidality: Patients may present with passive or active suicidal thoughts, with or without a specific plan or intent.
Psychotic Features: Approximately 20% of patients with MDD may experience delusions or hallucinations.
Clinical Pearl: Masked Depression
Be alert for "masked depression," where patients present to primary care physicians primarily with somatic complaints (e.g., insomnia, fatigue, weight changes) rather than overt sadness.
Objective Findings (Mental Status Exam):
Speech: May be slow, show increased latency, or be minimal.
Psychomotor Changes: Patients may exhibit psychomotor retardation (sitting quietly for hours, slowed movement/thinking) or psychomotor agitation (restlessness and severe nervousness).
Affect: May appear sad, tearful, irritable, flat, or blunted.
Thought Content: Often characterized by automatic negative thoughts or negative preoccupations.
Disruptive Mood Dysregulation Disorder (DMDD)
DMDD was introduced in the DSM-5 to address the massive increase in adolescent Bipolar Disorder diagnoses observed over the last two decades. It is a distinct diagnosis with a different prognosis and family history than Bipolar Disorder.
Diagnostic Criteria
To meet the criteria for DMDD, a patient must exhibit:
Severe, recurrent temper outbursts that are inconsistent with their developmental level.
Outbursts occurring ≥3 times per week.
A persistently irritable mood between outbursts.
Symptoms present for ≥12 months across ≥2−3 settings (e.g., home, school, peers).
Onset before age 10, with diagnosis typically made between ages 6 and 18.
Epidemiology and Treatment
The prevalence is estimated at 2%–5%, with a higher frequency in males. While DMDD shares overlapping symptoms with Oppositional Defiant Disorder, it carries an increased risk of developing anxiety or depressive disorders in adulthood. Treatment is most effective when it includes a parent component, such as multi-component programs.
Persistent Depressive Disorder (PDD)
Formerly known as Dysthymia, Persistent Depressive Disorder involves a more chronic, lower-intensity course of depression.
Diagnostic Criteria
Duration: Chronic depressive mood for ≥2 years. (In children/adolescents, the mood can be irritable and must last ≥1 year).
Associated Symptoms: At least two of the following: appetite changes, sleep disturbances, fatigue, low self-esteem, poor concentration, or hopelessness.
Continuity: Symptoms must be present for no more than 2 months at a time during the 2-year period.
Double Depression
A critical concept in PDD is "double depression," which occurs when a patient with underlying PDD experiences a superimposed Major Depressive Episode.
This graph illustrates the concept of double depression, showing a progression from normal mood through dysthymia and major depression, with a period of partial recovery.
Subtypes of PDD include:
Pure dysthymic syndrome.
With persistent major depressive episodes.
With intermittent major depressive episodes (with or without a current episode).
Treatment: Interventions include Cognitive Behavioral Therapy (CBT), interpersonal therapy, psychodynamic/insight-oriented therapy, lifestyle changes, and social supports.
Premenstrual Dysphoric Disorder (PMDD)
PMDD is a cyclical mood disorder specifically tied to the menstrual cycle.
Clinical Features
Prevalence: Affects 2–6% of menstruating women.
Timing: At least five cyclical symptoms must occur in the week before the onset of menses and lessen or disappear in the week following menses.
Symptoms: These include affective lability, anger/irritability, depressed mood, anxiety, anhedonia, difficulty concentrating, fatigue, appetite/sleep changes, feeling "out of control," or physical symptoms like headaches and bloating.
Clinical Note: Symptoms may worsen with stress, seasonal changes, or a history of trauma. Diagnosis is confirmed via two months of prospective symptom ratings.
Treatment: Per ACOG guidelines, management includes patient education, CBT, and routine exercise to manage physical and affective symptoms.
This occurs when the depressive mood or anhedonia develops in relation to intoxication, withdrawal, or exposure to a medication. Common substances involved include:
Other: Phencyclidine (PCP), hallucinogens, and inhalants.
Depressive Disorder Due to Another Medical Condition (GMC)
The mood disturbance must be secondary to a known medical condition. When diagnosing, the clinician must include the name of the disorder (e.g., "Depressive Disorder due to hypothyroidism"). Examples include stroke, Parkinson's disease, Huntington's disease, traumatic brain injury, and Cushing's disease.
Differential Diagnosis and Clinical Reasoning
Effective diagnosis requires a systematic approach: creating a broad list of potential diagnoses and narrowing it down by ruling in or ruling out specific conditions based on history, physical exams, and testing.
Grief vs. Major Depressive Disorder
It is vital to distinguish between bereavement (the loss of a person) and grief (the emotional response) from MDD.
Feature
Grief
Major Depression
Core Feeling
Emptiness and loss
Depressed mood/Anhedonia
Mood Pattern
Dysphoria decreases over days/weeks; positive emotions/humor can occur
Pervasive unhappiness and misery
Self-Esteem
Generally stable
Low self-esteem
Suicidal Ideation
Thoughts of "joining" the deceased
Thoughts of ending life due to worthlessness/pain
Exam Tip: If a patient presents with intensifying depression, weight loss, and suicidal ideation following a death, look closely at the timeline. If the symptoms are pervasive and include worthlessness (rather than just longing for the deceased), MDD is the more likely diagnosis.
Mental Status Examination (MSE) Framework
When conducting a clinical interview to assess for depression, the clinician should systematically evaluate:
General Appearance/Behavior
Speech (Rate, volume, latency)
Motor Activity (Agitation vs. Retardation)
Mood (Subjective) and Affect (Objective)
Thought Process (Linearity, logic)
Thought Content (Delusions, suicidal ideation, ruminations)
Insight and Judgment
Cognition (Concentration, memory).
Keep reading for free.
Create an account to finish this reading and make it part of your study routine.
